当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析 - 现金流量表

前沿生物-U

(688221)

  

流通市值:55.06亿  总市值:55.06亿
流通股本:3.75亿   总股本:3.75亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金51,351,668.5525,672,208.61173,854,060.54115,504,867.79
  收到其他与经营活动有关的现金5,224,719.411,939,895.817,694,401.9915,994,882.05
  经营活动现金流入小计56,576,387.9627,612,104.41191,548,462.53131,499,749.84
  购买商品、接受劳务支付的现金14,801,676.937,188,686.6359,529,551.1931,442,890.87
  支付给职工以及为职工支付的现金57,156,170.5333,366,648.78125,449,789.5996,818,734.34
  支付的各项税费1,575,699.89789,232.134,210,447.283,037,483.59
  支付其他与经营活动有关的现金81,270,682.334,936,864.95174,874,986.52134,125,563.54
  经营活动现金流出小计154,804,229.6576,281,432.49364,064,774.58265,424,672.34
  经营活动产生的现金流量净额-98,227,841.69-48,669,328.08-172,516,312.05-133,924,922.5
二、投资活动产生的现金流量:
  取得投资收益收到的现金7,184,561.173,548,498.3415,618,377.611,874,308.83
  处置固定资产、无形资产和其他长期资产收回的现金净额28,00028,00025,69025,690
  处置子公司及其他营业单位收到的现金净额15,128,712.33-48,663,920.1510,000,000
  收到的其他与投资活动有关的现金1,534,298,100852,460,0003,376,840,0002,432,520,000
  投资活动现金流入小计1,556,639,373.5856,036,498.343,441,147,987.752,454,419,998.83
  购建固定资产、无形资产和其他长期资产支付的现金23,669,991.9617,392,130.9118,601,345.5416,948,950.27
  支付其他与投资活动有关的现金1,442,550,000776,260,0003,613,328,1002,806,038,100
  投资活动现金流出小计1,466,219,991.96793,652,130.913,631,929,445.542,822,987,050.27
  投资活动产生的现金流量净额90,419,381.5462,384,367.43-190,781,457.79-368,567,051.44
三、筹资活动产生的现金流量:
  取得借款收到的现金216,774,00039,000,000393,926,406.17324,609,468.99
  筹资活动现金流入小计216,774,00039,000,000393,926,406.17324,609,468.99
  偿还债务支付的现金289,433,314.3780,819,598.05285,140,067.94259,750,419.95
  分配股利、利润或偿付利息支付的现金4,520,884.012,420,320.5114,909,560.8112,596,861.42
  支付其他与筹资活动有关的现金-179,5218,264,0792,447,810
  筹资活动现金流出小计293,954,198.3883,419,439.56308,313,707.75274,795,091.37
  筹资活动产生的现金流量净额-77,180,198.38-44,419,439.5685,612,698.4249,814,377.62
四、汇率变动对现金及现金等价物的影响-15,167.51-4,608.064,532.3313,432.76
五、现金及现金等价物净增加额-85,003,826.04-30,709,008.27-277,680,539.09-452,664,163.56
  加:期初现金及现金等价物余额248,719,957.82248,719,957.82526,400,496.91526,400,496.91
  期末现金及现金等价物余额163,716,131.78218,010,949.55248,719,957.8273,736,333.35
补充资料:
  净利润-97,352,610.68--201,382,610.39-
  资产减值准备89,923.13-46,727,551.35-
  固定资产和投资性房地产折旧9,121,391.86-15,479,494.94-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,121,391.86-15,479,494.94-
  无形资产摊销10,998,831.51-24,296,348.74-
  长期待摊费用摊销299,227.67-479,051.25-
  处置固定资产、无形资产和其他长期资产的损失-15,353.93--18,798.64-
  固定资产报废损失--52,830.32-
  公允价值变动损失297,011.44--83,505.51-
  财务费用3,796,838.12-11,335,662.14-
  投资损失1,861,944.89--84,091,885.06-
  存货的减少-13,804,530.31-9,488,617.28-
  经营性应收项目的减少-1,825,792.17-38,598,114.15-
  经营性应付项目的增加-13,385,260.26--35,107,090.08-
  现金的期末余额163,716,131.78-248,719,957.82-
  减:现金的期初余额248,719,957.82-526,400,496.91-
  现金及现金等价物的净增加额-85,003,826.04--277,680,539.09-
公告日期2025-08-302025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑